Cargando...
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
BACKGROUND: Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-related genes...
Guardado en:
| Publicado en: | Mol Med |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584997/ https://ncbi.nlm.nih.gov/pubmed/31221082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-019-0098-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|